Skip to content
  • About
    • Who We Are
    • Leadership
  • Services
    • Amplity Medical →
    • Amplity Commercial →
    • Amplity Intel →
    • Amplity MedComms →
    • Amplity Learn →
    • Amplity Recruiting →
  • Expertise
  • Our Work
  • Our News
  • Careers
  • About
    • Who We Are
    • Leadership
  • Services
    • Amplity Medical →
    • Amplity Commercial →
    • Amplity Intel →
    • Amplity MedComms →
    • Amplity Learn →
    • Amplity Recruiting →
  • Expertise
  • Our Work
  • Our News
  • Careers
Contact

Next‑Gen AnswerY™: Arriving July 2026

Next‑Gen AnswerY™: Arriving July 2026

CTLs Drive Global Trial Success 6 Weeks Early

Burden & Treatment Patterns Associated With Dravet And Lennox-Gastaut Syndromes

Remote Sales Team = 104% TRx Growth

Exploring The Clinical Burden Of Dravet Syndrome & Lennox-Gastaut Syndrome 

NLP Unlocks Patterns In Myasthenia Gravis Progression

Study Unlocks MG Subtypes + Severity From Notes

Study Finds Tolerable ASM For Refractory Epilepsy 

Burden Of Alzheimer’s On Patients & Caregivers

AnswerY Delivers 19:1 ROI

63 Rare Disease Patient Starts

Amplity.svg
About
Who We Are
Leadership
Services
Amplity Medical
Amplity Commercial
Amplity Intel
Amplity MedComms
Amplity Learn
Amplity Recruiting
Expertise
Our Work
Our News
Articles
Events
Research
Careers
Contact
Amplity
2050 Cabot Blvd. West #110
Langhorne, PA 19047
© 2026 Amplity, Inc. All Rights Reserved.
Privacy & Cookie Statements
Terms of Use
Site Map